Literature DB >> 16774615

Current practice of insulin pump therapy in children and adolescents - the Hannover recipe.

Thomas Danne1, Wolfgang von Schütz, Karin Lange, Claudia Nestoris, Nicolin Datz, Olga Kordonouri.   

Abstract

Increasing evidence points to the importance of achieving low blood glucose variability and also a low hemoglobin A1c (HbA1c) to prevent diabetic late complications. Continuous subcutaneous insulin infusion (CSII) is associated with lower blood glucose variability in children. Frequent indications for starting CSII in youth are recurrent hypoglycemia, need for increased flexibility, poor glycemic control, dawn phenomenon, or needle phobia. At our center, about one-third of all patients across all age groups are currently on CSII. Although the average glycemic control is not very different from those on multiple daily injections, fewer patients are seen in the segment of very high and very low HbA1c with CSII. Across centers, the 'recipes' tailoring CSII treatment to individual patients and cultures are based more on experience than on evidence. However, several typical pediatric features have been identified. Patterns of the hourly basal rate and prandial insulin requirements vary with age. While many adolescents have increased requirements at dawn and dusk, young children show increasing needs in the second half of the day. Low insulin requirements, particularly in neonates, may need insulin dilution. The selection of catheters and needles has to be appropriate for the age. The opportunity to have an electronic memory read-out of all entries and alarms offers new possibilities of therapeutic monitoring, particularly in those youth not keeping good logbooks. This feature can be helpful, if a trustful relationship between the diabetes team and the family is established.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16774615     DOI: 10.1111/j.1399-543X.2006.00166.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  20 in total

Review 1.  New developments in the treatment of type 1 diabetes in children.

Authors:  Thomas Danne; Karin Lange; Olga Kordonouri
Journal:  Arch Dis Child       Date:  2007-11       Impact factor: 3.791

2.  Experiences of Adults Using Continuous Subcutaneous Insulin Infusion: A Qualitative Study.

Authors:  Naglaa Ibrahim Mesbah; Nehad Abd-El-Raheem Taha; Zahra Nema Rahme; Faten Fawzi Sukkar; Dina Mohamed Omar
Journal:  Med Princ Pract       Date:  2019-09-27       Impact factor: 1.927

3.  Effectiveness of groups for adolescents with type 1 diabetes mellitus and their parents.

Authors:  Jessica C Kichler; Astrida S Kaugars; Patricia Marik; Laura Nabors; Ramin Alemzadeh
Journal:  Fam Syst Health       Date:  2013-08-19       Impact factor: 1.950

4.  Insulin doses before and one year after pump start: children have a reversed dawn phenomenon.

Authors:  Tom Nicolajsen; Andreas Samuelsson; Ragnar Hanas
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

Review 5.  100 Years of Insulin: Lifesaver, immune target, and potential remedy for prevention.

Authors:  Anette-Gabriele Ziegler; Thomas Danne; Carolin Daniel; Ezio Bonifacio
Journal:  Med (N Y)       Date:  2021-09-15

Review 6.  [Diabetes mellitus - perioperative management].

Authors:  P Rittler; U C Broedl; W Hartl; B Göke; K Jauch
Journal:  Chirurg       Date:  2009-05       Impact factor: 0.955

7.  [Guidelines for insulin pump therapy in children and adults].

Authors:  Marietta Stadler; Sandra Zlamal-Fortunat; Ingrid Schütz-Fuhrmann; Birgit Rami-Merhar; Edith Schober; Alexandra Kautzky-Willer; Raimund Weitgasser; Rudolf Prager; Martin Bischof
Journal:  Wien Klin Wochenschr       Date:  2012-12       Impact factor: 1.704

8.  Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries.

Authors:  T Danne; T Battelino; P Jarosz-Chobot; O Kordonouri; E Pánkowska; J Ludvigsson; E Schober; E Kaprio; T Saukkonen; M Nicolino; N Tubiana-Rufi; C Klinkert; H Haberland; A Vazeou; L Madacsy; D Zangen; V Cherubini; I Rabbone; S Toni; C de Beaufort; W Bakker-van Waarde; N van den Berg; I Volkov; R Barrio; R Hanas; U Zumsteg; B Kuhlmann; C Aebi; U Schumacher; S Gschwend; P Hindmarsh; M Torres; N Shehadeh; M Phillip
Journal:  Diabetologia       Date:  2008-07-01       Impact factor: 10.122

9.  Metabolic control of TYPE 1 Diabetes in children treated with insulin pump therapy.

Authors:  Snijezana Hasanbegović; Edo Hasanbegović
Journal:  Bosn J Basic Med Sci       Date:  2009-05       Impact factor: 3.363

10.  Initial Basal and Bolus Rates and Basal Rate Variability During Pump Treatment in Children and Adolescents

Authors:  Günay Demir; Yasemin Atik Altınok; Samim Özen; Şükran Darcan; Damla Gökşen
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.